Apollo Hospital has guided that the demerged entity (NewCo) is expected to achieve Rs 250 billion in revenue by FY27, with a targeted Ebitda margin of 7%, driven by the scale-up of digital health services and deeper pharmacy penetration. (Source: Company website)
The demerger allows for a sharper strategic focus, with Apollo Hospitals Enterprise Ltd. concentrating on core healthcare services, while NewCo drives growth in digital health and pharmacy distribution under dedicated leadership.